S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|Pluristem Wins Cell Therapy Patent Case in Europe; European Patent Office Confirms Validity of Amended Claims|
|Pluristem Advances Its Second Major Cell Therapy Product Line From Development to Large-Scale Manufacturing|
|Case Western Reserve University to Study Pluristem's PLX-RAD Cells in Umbilical Cord Blood Transplants for the Treatment of Blood Cancers and Genetic Diseases|
|Pluristem CEO Zami Aberman to Present at Two Regenerative Medicine Conferences in London on November 12 and 13, 2014|
|Pluristem Granted Patents in Australia and New Zealand for Use of Placental Cells in the Treatment of Multiple Indications|
|Pluristem's Dr. Ohad Karnieli to Present at Two Upcoming Scientific Conferences|
|Pluristem Granted Patent in Singapore for Its 3D Cell Expansion Technology|
|Pluristem and Hadassah Medical Center Will Collaborate to Study Potential of PLX-RAD Cells to Improve Bone Marrow and Umbilical Cord Blood Transplant Outcomes|
|Pluristem Granted Patent for Foundational Cell Harvesting Technology in South Africa|
|New Published Data Show Pluristem's PLX Cells Protect Neurons|
Click above to view more mutual fund data and stats for 4109 - Stella Chemifa Corp.